Eli Lilly and Company

Advisor Statistics - HTA

United Kingdom

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, BiotechnologyIndustries

Job Description

Employment Type: Full time

Company Information

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Position Overview

Within the Global Statistics organization, Advanced Analytics and Access Capabilities is the global center of expertise for all statistical aspects of Patient Access, Health Technology Assessment (HTA) and Real-World Evidence (RWE). Within this center, the HTA Statistics Team provides input and statistical leadership to evidence generation plans and Access & Reimbursement projects to accelerate patient access in collaboration with multiple partners from other functions, geographies, and affiliations.

Responsibilities

General Scope

The job tasks listed below outline the scope of the position. The application of these tasks may vary, based upon current business needs.

  • Be a successful problem solver who can bring to bear technical expertise to work closely with other functions to answer important questions about our products by translating strategic needs into innovative statistical solutions.
  • Provide technical statistical leadership to data-related research in Health Technology Assessment (HTA) and reimbursement to improve the success of the compound, considering requirements across the globe (US, Europe, Asia Pacific, and other geographies).
  • Utilize the most efficient or innovative approach in economic modeling, (network)-meta-analysis and indirect comparisons, and clinical trials.
  • Stay up-to-date with respect to statistical methodology, particularly in methods applicable to the research area of HTA, to maintain proficiency in applying new and varied methods, and to be competent in justifying methods selected.
  • Ensure high-quality statistical support for projects through the oversight of external suppliers and provide input into outsourcing strategy and processes.
  • Influence cross-functional team members regarding appropriate research methods.

Communication of Results and Inferences

  • Collaborate with team members to write reports and communicate results.
  • Assist with, or be responsible for, communicating study results via payer submissions, publications, or oral presentations in group settings, as well as for communicating one-on-one with key customers and presenting at scientific meetings.
  • Support responses to payer queries and/or interactions.
  • Actively contribute to internal and external scientific interactions with decision-making agencies and healthcare professionals.

Therapeutic Area Knowledge

  • Understand disease states, competitive landscapes, and regulatory/payer environments to enhance the level of customer focus and collaboration as a strong scientific contributor.

Statistical Leadership and Teamwork

  • Introduce and apply innovative methodology and tools to solve critical problems.
  • Merge scientific thinking and business knowledge to identify issues, evaluate options, and implement solutions.
  • Lead projects independently and work effectively across functions.
  • Apply technical expertise to influence business decisions.
  • Actively contribute to brand strategy and portfolio decisions in cross-functional governance bodies.

Qualifications

Basic Qualification

  • PhD with 3+ years of experience or MSc degree with 6+ years of experience in statistics or a related field.

Additional Preferences

  • Expertise in HTA, health outcomes research, and/or real-world evidence is required.
  • Significant experience in Health Technology Assessment in major markets.
  • Excellent knowledge of statistical theory and methodology, with a solid understanding of experimental design and causal inference.

Skills

Statistical analysis
Health Technology Assessment (HTA)
Meta-analysis
Economic modeling
Clinical trials
Data analysis
Reimbursement strategies

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI